Arrhythmic Risk in Carriers of Predicted Deleterious Rare Variants in Dilated and Arrhythmogenic Cardiomyopathy Genes. [PDF]
Gandin I +11 more
europepmc +1 more source
Long‐Term Use of Rezafungin: A Case Report and Insights Into Real‐World Access
Transplant Infectious Disease, EarlyView.
Jian Mei Li +2 more
wiley +1 more source
ABSTRACT Previous studies suggest that genetic risk factors for dilated cardiomyopathy (DCM) in Dobermann dogs may differ between populations, complicating the use of genetic tests across subpopulations. Variants in pyruvate dehydrogenase kinase 4 (PDK4) and titin (TTN) have been associated with DCM in North American Dobermanns, whereas two loci on ...
Alma H. Hulsman +15 more
wiley +1 more source
Trypanosoma cruzi Cardiomyopathy Diagnosed via Explant Tissue 28S Ribosomal Gene Sequencing Following Orthotopic Heart Transplantation. [PDF]
Fernandez AC +3 more
europepmc +1 more source
ABSTRACT U2 small nuclear RNA auxiliary factor 2 (U2AF2) is an essential pre‐mRNA splicing factor involved in the early stages of pre‐mRNA splicing. To date, multiple individuals have been reported with predominantly heterozygous missense variants presenting intellectual disability, speech and motor delays, seizures, hypotonia, and thin or hypoplastic ...
Amanda Toledo +3 more
wiley +1 more source
Genetic Testing After Heart Transplantation Uncovers Heritable Disease and Drives Family Screening. [PDF]
Moliner-Abós C +33 more
europepmc +1 more source
Lung‐Cardiovascular Interactions and Derangements in ARDS
This review proposes an anatomical near‐ and far‐field framework for lung‐cardiovascular interactions in ARDS. Grounded in pathological and biological studies, the evidence spans pulmonary vascular, right ventricular, and systemic endothelial derangements and reviews available evidence for targeted therapies.
Pablo A. Sanchez +4 more
wiley +1 more source
Temporal trends and post-transplant outcomes in anthracycline-induced cardiomyopathy: A contemporary United Network for Organ Sharing analysis. [PDF]
Osorio MF +4 more
europepmc +1 more source
SGLT2i in heart failure: Cardiorenal mechanisms, clinical evidence and translational perspectives
SGLT2 inhibitors improve heart failure outcomes through integrated cardiorenal mechanisms. In the kidney, they reduce glucose and sodium reabsorption, promoting natriuresis, osmotic diuresis and renal protection. In the heart, they enhance myocardial energetics, reduce inflammation, oxidative stress, fibrosis and adverse remodelling, resulting in fewer
Jelica Grujic‐Milanovic +4 more
wiley +1 more source
Clinical Variability Including Non-Dilated Left Ventricular and Dilated Cardiomyopathy in a Pedigree With an Intragenic CTNNA3 Copy Number Variation. [PDF]
Fusco C +8 more
europepmc +1 more source

